FDA clears expanded matrix of sizes for TMI's Chocolate PTA balloon catheter

NewsGuard 100/100 Score

TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for an expanded matrix of sizes for its Chocolate™ PTA balloon catheter. Chocolate™ is now approved for the percutaneous transluminal treatment of lesions in the peripheral vasculature in balloon diameters from 2.0 - 4.0mm and in balloon lengths up to 120mm.

"This latest regulatory approval broadening the available size matrix of the Chocolate™ PTA Balloon marks yet another important milestone for TriReme Medical," said Eitan Konstantino, President and CEO of TriReme Medical Inc. "There is more to come; our goal is to provide a broad range of innovative tools to improve outcomes in patients suffering from complex vascular disease."

"Chocolate™ has become an essential part of my routine practice for treating below the knee lesions," said Dr. Rajesh Dave, Chief Medical Executive and Director at Cardiac Catheterization Laboratories, Holy Spirit Cardiovascular Institute, Camp Hill, PA. "With the approval of these new sizes, I will be able to expand my use of Chocolate™ and begin to treat patients with disease in the popliteal artery where we usually prefer not to stent."

Source:

TriReme Medical, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows comparable outcomes for TAVR and SAVR in aortic valve replacement